Access insightful, webinars that provide insight and customer experiences into stable cell line development resources and commentary. Learn how our cell line development technology has been used by customers to produce stable cell lines.
Osmolality, a CQA for Cell Line Development and Cell Therapy
October 2021 - In this webinar, Dr Mark Rothenberg (Associate Director in Scientific Applications, Advanced Instruments) and Dr Ian Taylor (Director of Business Development, Advanced Instruments, Solentim) discuss the use of osmolality as a key surrogate analytic for cell health and viability in both transient transfections and stable producer Cell Line Development.
Robust workflow for single cell cloning of iPSCs
June 2021 - In this webinar, Ian Taylor (Chief Business Officer at Solentim) presents a platform combination of instrumentation (the VIPS™) and soluble matrix (MatriClone™, based on laminin) for the high-efficiency, high-viability single-cell cloning of iPSCs to form cGMP Master Cell Banks. View the poster presentation co-authored by Dr Claire Richards, Dr Philip D. Manos and Dr Ian Taylor, entitled “A robust and semi-automated hiPSC gene editing workflow”.
Assurance rich workflows for cell and gene therapy
May 2021 - In this webinar, Duncan Borthwick (Global Marketing Manager at Solentim) describes advances in clonally based workflows including cell line development, gene therapy and cell therapy. Learn more about Regulatory and practical benefits of clonally-derived workflows and how these come together under a data management system.
Robust workflow for single cell cloning of iPSCs
May 2021 - In this webinar, Dr Ian Taylor (Chief Business Officer at Solentim) presents a platform combination of instrumentation (the VIPS™) and soluble matrix (MatriClone™, based on laminin) for the high-efficiency, high-viability single-cell cloning of iPSCs to form cGMP Master Cell Banks. This includes an industry-leading clonality documentation package to support future investigational new drugs (INDs).
A New Data-Driven Workflow for CLD & Live Lab
March 2021 - In this webinar, Duncan Borthwick (Global Marketing Manager at Solentim) explores the award winning ICON™ and the overarching data management system STUDIUS™ from Solentim, two new products for cell line development. View the Live Lab video and experience the new technologies and how these tie in with a new integrated ecosystem to provide a new perspective on assurance based workflows.
A New Platform for Clinical Gene Editing of iPSCs
February 2021 - In this webinar, Dr Ian Taylor (Chief Business Officer at Solentim) and Simon Hoffman (GMP Consultant) explore a platform combination of instrumentation (the VIPS™) and soluble matrix (MatriClone™, based on laminin) for the high-efficiency, high-viability single-cell cloning of iPSCs to form the Master Cell Bank within a cGMP environment.
A Data-Driven Workflow For Cell Line Development
February 2021 - In this webinar, Duncan Borthwick, Mark Stockdale and Ian Taylor explore Solentim's new technologies for cell line development, ICON and STUDIUS. Learn about the practicalities of integrating data-centric decision making into the cell therapy development process and how new levels of assurance, data integrity and and process management can build into a more confident investigational new drug (IND) submission.
Launch of STUDIUS™ & ICON™
January 2021 - In this webinar, Solentim introduce two new products, an instrument named ICON, that is designed to empower laboratories to make better decisions faster, and an over-arching platform called STUDIUS. Learn about how these two new products work to provide a new data-driven workflow for the development of modern cell-based therapies.
January 2021 - In this webinar, Duncan Borthwick and Mark Stockdale introduce two novel products. ICON is the world’s first benchtop system for characterizing high productivity clones and STUDIUS the new standard for cell line development. In this launch presentation learn about how these two new products build together with existing Solentim platforms to build a new data driven workflow for the development of modern cell based therapies.
New Standards in Efficient Single Cell Cloning of hiPSCs
September 2020 - In this webinar, Ian Taylor (Chief Business Officer at Solentim) and Philip Manos (Founder, President & Scientific Director at EverCell Bio) discuss how numerous hiPSC cell lines can be successfully subcloned in a robust and automated fashion using the VIPS™ single cell cloning instrument in combination with a new soluble matrix called MatriClone™ , thereby reducing time and cost while most importantly maintaining the integrity of clonal biology.
Leaping Ahead with the Latest Technology
June 2020 - In this webinar, Mark Stockdale and Oren Beske, Amalgamators of Business and Biology at Solentim and ATUM respectively, discuss the essential pillars of cell line development, the practices revolutionizing workflow efficacy, and the best technologies to streamline your lab. They focus on accelerating cell line development (CLD) while maintaining the quality of the process, increasing efficiency and decreasing regulatory queries.
Advanced Cell Growth Supplements
June 2020 - In this webinar, Duncan Borthwick (Solentim), Steve Game and Alasdair Robertson (Founding Directors of SAL Scientific) discuss the cell growth supplements range from SAL, and how they are revolutionizing workflow efficiency and speed. The team explore the key stages of the cell line development workflow, and the impact of supplements on each.
Reliable single cell outgrowth - Dark art or Science?
October 2019 - In this GEN webinar, we discuss how the VIPS™ system, in combination with the InstiGRO™ single-cell cloning supplements offer customers a high-efficiency solution which ensures plates are populated with high numbers of healthy single cells that grow into resultant colonies for screening, expansion and ultimately selection for master cell banks..
Need to know more information about Solentim?
and how we can accelerate your Cell Line Development Projects ....